To meet the demand for innovative treatments based on cell therapy, it’s essential that Johnson&Johnson delivers solutions that are both faster and more cost-effective. Optimizing lentiviral vector (LVV) design and production is critical for advancing a subset of these therapies like CAR-T. The primary challenge lies in developing scalable production systems that achieve high viral […]
FAST’s webinar series on challenges in ATMP innovation Advanced Therapy Medicinal Products (ATMPs) promise to transform patient care and revolutionize health care. However, developers often face significant challenges in getting these innovative therapies to patients. Common questions include: How can you meaningfully engage patients in your ATMP research?What does it take to effectively design and […]
FAST’s webinar series on challenges in ATMP innovation Advanced Therapy Medicinal Products (ATMPs) promise to transform patient care and revolutionize health care. However, developers often face significant challenges in getting these innovative therapies to patients. Common questions include: How can you meaningfully engage patients in your ATMP research?What does it take to effectively design and […]
Watch the webinar here. Use passcode: b4UGM=Xi
Watch the webinar here. Use the password: *5w7gi?D
Cell-based advanced therapy medicinal products (ATMPs) such as CAR T, CAR NK, TIL and TCR T therapies represent an emerging form of cancer treatment wherein engineered immune cells form the basis of the therapy. However, the complex techniques needed to generate ATMPs, and the biological demands to make them effective for various cancer types, present […]
In this webinar Dr. Ana Hidalgo-Simon will give an overview on the journey of ATMP development and what the future holds. You can view the webinar here.
This event invites innovators to present solutions which can compress the vein-to-vein timeline and unlock the full potential of CAR-T therapy for more patients, faster. One of the speakers also showcases their innovation in in vivo gene therapy as a next generation solution. You can press here to watch the webinar.
The European Medicines Agency organises a webinar bringing together regulators and medicine developers to discuss the use of platform approaches beyond the quality and manufacturing domains. The proposal for the EU pharmaceutical legislation introduces the concepts of platform technologies and platform marketing authorisation. The main objectives of the webinar are: Clarifying the current EU legal framework […]
The Join4ATMP project has announced the launch of its 2026 webinar series, aimed at exploring how patient involvement can transform the design of Advanced Therapy Medicinal Product (ATMP) clinical trials. The first session is titled “Listening to Experiences: The Impact of Patient Involvement in ATMP Clinical Trial Design". Find more information on the series and to registere here.